Visiopharm’s Discovery platform bridges the gap between expert domain knowledge and scalable, objective analysis on human or animal tissue with AI-powered software. Researchers can use Discovery to study the biology of disease, identify druggable targets, or develop companion diagnostics. Without having to code, the platform allows users to develop customized algorithms tailored to their research. That means you are in the driver’s seat and AI serves as a powerful extension—not replacement—of human knowledge to advance precision medicine.